Takeuchi, K., Takeda, M., Miyajima, N., Kobune, F., Tanabayashi, K. & Tashiro, M. (2002). Recombinant wild-type and edmonston strain measles viruses bearing heterologous H proteins: role of H protein in cell fusion and host cell specificity. J Virol 76, 4891-900. Tamin, A., Rota, P. A., Wang, Z. D., Heath, J. L., Anderson, L. J. & Bellini, W. J. (1994). Antigenic analysis of current wild type and vaccine strains of measles virus. J Infect Dis 170, 795-801. Tanaka, K., Minagawa, H., Xie, M. F. & Yanagi, Y. (2002). The measles virus hemagglutinin downregulates the cellular receptor S<strong>LA</strong>M (CD150). Arch Virol 147, 195-203. Tangye, S. G., Phillips, J. H. & Lanier, L. L. (2000). The CD2-subset of the Ig superfamily of cell surface molecules: receptor-ligand pairs expressed by NK cells and other immune cells. Semin Immunol 12, 149-57. Tatsuo, H., Ono, N., Tanaka, K. & Yanagi, Y. (2000). S<strong>LA</strong>M (CDw150) is a cellular receptor for measles virus. Nature 406, 893-7. Taylor, M. J., Godfrey, E., Baczko, K., ter Meulen, V., Wild, T. F. & Rima, B. K. (1991). Identification of several different lineages of measles virus. J Gen Virol 72, 83-8. Taylor, J., Weinberg, R., Tartaglia, J., Richardson, C., Alkhatib, G., Briedis, D., Appel, M., Norton, E. & Paoletti, E. (1992). Nonreplicating viral vectors as potential vaccines: recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins. Virology 187, 321-8. Thacker, S. B. & Millar, J. D. (1991). Mathematical modeling and attempts to eliminate measles: a tribute to the late Professor George Macdonald. Am J Epidemiol 133, 517- 25. Tidjani, O., Grunitsky, B., Guerin, N., Levy-Bruhl, D., Lecam, N., Xuereff, C. & Tatagan, K. (1989). Serological effects of Edmonston-Zagreb, Schwarz, and AIK-C measles vaccine strains given at ages 4-5 or 8-10 months. Lancet 2, 1357-60. Toivanen, P., Mantyjarvi, R. & Hirvonen, T. (1968). Maternal antibodies in human foetal sera at different stages of gestation. Immunology 15, 395-403. Tourtellotte, W. W., Ma, B. I., Brandes, D. B., Walsh, M. J. & Potvin, A. R. (1981). Quantification of de novo central nervous system IgG measles antibody synthesis in SSPE. Ann Neurol 9, 551-6. Truong, A. T., Kreis, S., Ammerlaan, W., Hartter, H. K., Adu, F., Omilabu, S. A., Oyefolu, A. O., Berbers, G. A. & Muller, C. P. (1999). Genotypic and antigenic characterization of hemagglutinin proteins of African measles virus isolates. Virus Res 62, 89-95. 167
Truong, A. T., Mulders, M. N., Gautam, D. C., Ammerlaan, W., de Swart, R. L., King, C. C., Osterhaus, A. D. & Muller, C. P. (2001). Genetic analysis of Asian measles virus strains--new endemic genotype in Nepal. Virus Res 76, 71-8. Tyrell, D. & Ehrnst, A. (1979). Transmembrane communication in cells chronically infected with measles virus. J Cell Biol 81, 396-402. Udem, S. A. & Cook, K. A. (1984). Isolation and characterization of measles virus intracellular nucleocapsid RNA. J Virol 49, 57-65. van-Binnendijk, R., Poelen, M., Kuijpers, K., Osterhaus, A. & Uytde-Haag, F. (1990). The predominance of CD8 T-cells after infection with measles virus suggest a role for CD8 class1 MHC-restricted cytotoxic T-lymphocytes (CTL) in recovery from measles. J Immunol 144, 2394-9. van Binnendijk, R. S., Poelen, M. C., van Amerongen, G., de Vries, P. & Osterhaus, A. D. (1997). Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies. J Infect Dis 175, 524-32. van den Hoogen, B. G., de Jong, J. C., Groen, J., Kuiken, T., de Groot, R., Fouchier, R. A. & Osterhaus, A. D. (2001). A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 7, 719-24. Varsanyi, T. M., Utter, G. & Norrby, E. (1984). Purification, morphology and antigenic characterization of measles virus envelope components. J Gen Virol 65, 355-66. Varsanyi, T. M., Morein, B., Love, A. & Norrby, E. (1987). Protection against lethal measles virus infection in mice by immune- stimulating complexes containing the hemagglutinin or fusion protein. J Virol 61, 3896-901. Vingershoets, J., Goilav, C., Vanham, G. & al., e. (1995). Non response to a recombinant pre- S2-containing hapatitis B vaccine : association with the H<strong>LA</strong> system. Annales de la Société Belge Medécine Tropicale 75, 125-9. Volckaert-Vervliet, G. & Billiau, A. (1977). Induction of interferon in human lymphoblastoid cells by Sendai and measles viruses. J Gen Virol 37, 199-203. Von Pirquet C. (1908). Verhalten der kutanen tuberkulin-reaktion wahrend der Masern. Dtsch Med Wochenschr 34, 1297-1300. Wakefield, A. J., Sim, R., Akbar, A. N., Pounder, R. E. & Dhillon, A. P. (1997). In situ immune responses in Crohn's disease: a comparison with acute and persistent measles virus infection. J Med Virol 51, 90-100. 168
- Page 1 and 2:
UNIVERSITE JOSEPH FOURIER-GRENOBLE
- Page 3 and 4:
Je remercie le Dr Florence PRADEL e
- Page 5 and 6:
II.3 2. Les nouveaux vaccins……
- Page 7 and 8:
VI.3. La rougeole au Cameroun : Etu
- Page 9 and 10:
CHAPITRE I : LE VIRUS DE LA ROUGEOL
- Page 11 and 12:
I.Le virus de la rougeole 2. Classi
- Page 13 and 14:
I.Le virus de la rougeole 3. Struct
- Page 15 and 16:
I.Le virus de la rougeole 4. Struct
- Page 17 and 18:
I.Le virus de la rougeole 4. Struct
- Page 19 and 20:
I.Le virus de la rougeole 5. Cycle
- Page 21 and 22:
I.Le virus de la rougeole 5. Cycle
- Page 23 and 24:
Récepteur cellulaire Etat natif H
- Page 25 and 26:
I.Le virus de la rougeole 6. Pathol
- Page 27 and 28:
I.Le virus de la rougeole 6. Pathol
- Page 29 and 30:
I.Le virus de la rougeole 6. Pathol
- Page 31 and 32:
I.Le virus de la rougeole 6. Pathol
- Page 33 and 34:
II. La vaccination 1. Les vaccins i
- Page 35 and 36:
II. La vaccination 2. Les vaccins v
- Page 37 and 38:
Figure 6 : Souches vaccinales utili
- Page 39 and 40:
II. La vaccination 3. Les nouvelles
- Page 41 and 42:
II. La vaccination 3. Les nouvelles
- Page 43 and 44:
II. La vaccination 4. Position actu
- Page 45 and 46:
CHAPITRE III. ETUDES EPIDEMIOLOGIQU
- Page 47 and 48:
III. Etudes épidémiologiques 1. I
- Page 49 and 50:
III. Etudes épidémiologiques 2. P
- Page 51 and 52:
III. Etudes épidémiologiques 4. R
- Page 53 and 54:
III. Etudes épidémiologiques 4. R
- Page 55 and 56:
III. Etudes épidémiologiques 4. R
- Page 57 and 58:
III. Etudes épidémiologiques 5. P
- Page 59 and 60:
III. Etudes épidémiologiques 5. P
- Page 61 and 62:
IV. Epidémiologie moléculaire du
- Page 63 and 64:
IV. Epidémiologie moléculaire du
- Page 65 and 66:
IV. Epidémiologie moléculaire du
- Page 67 and 68:
IV. Epidémiologie moléculaire du
- Page 69 and 70:
IV. Epidémiologie moléculaire du
- Page 71 and 72:
IV. Epidémiologie moléculaire du
- Page 73 and 74:
V. La rougeole en Afrique 1. La rou
- Page 75 and 76:
V. La rougeole en Afrique 1. La rou
- Page 77 and 78:
V. La rougeole en Afrique 1. La rou
- Page 79 and 80:
Figure 8: Répartition des cas de r
- Page 81 and 82:
V. La rougeole en Afrique 2. La rou
- Page 83 and 84:
VI. Etude des souches Africaines du
- Page 85 and 86:
VI. Etude des souches Africaines du
- Page 87 and 88:
VI. Etude des souches Africaines du
- Page 89 and 90:
VI.1.4. Article 1 : Adaptation des
- Page 91 and 92:
1506 NOTES J. VIROL. FIG. 1. MV inf
- Page 93 and 94:
1508 NOTES J. VIROL. FIG. 3. Flow c
- Page 95 and 96:
VI. Etude des souches Africaines du
- Page 97 and 98:
Figure 9 : Répartition géographiq
- Page 99 and 100:
VI. Etude des souches Africaines du
- Page 101 and 102:
VI. Etude des souches Africaines du
- Page 103 and 104:
Measles virus strains circulating i
- Page 105 and 106:
In 1983, measles viruses isolated i
- Page 107 and 108:
obtained for the two 1983 isolates
- Page 109 and 110:
easons. The available data for meas
- Page 111 and 112:
Malvoisin E, Wild TF. 1990. Contrib
- Page 113 and 114:
106 0.005 100 82 100 86 98 New York
- Page 115 and 116:
Table 1 : African measles strains u
- Page 117 and 118:
VI.3. LA ROUGEOLE AU CAMEROUN : ETU
- Page 119 and 120:
VI. Etude des souches Africaines du
- Page 121 and 122:
VI. Etude des souches Africaines du
- Page 123 and 124: VI. Etude des souches Africaines du
- Page 125 and 126: VI. Etude des souches Africaines du
- Page 127 and 128: VI. Etude des souches Africaines du
- Page 129 and 130: CHAPITRE VII. DISCUSSION 122
- Page 131 and 132: VII. Discussion 1. Interaction viru
- Page 133 and 134: VII. Discussion 1. Interaction viru
- Page 135 and 136: VII. Discussion 2. Epidémiologie C
- Page 137 and 138: VII. Discussion 2. Epidémiologie f
- Page 139 and 140: CHAPITRE VIII. CONCLUSION ET PERSPE
- Page 141 and 142: ANNEXES 134
- Page 143 and 144: Consensus ATATCCATCA TGGGTCTCAA GGT
- Page 145 and 146: Consensus MTEIYDFDKS AWDIKGSIAP IQP
- Page 147 and 148: Consensus ATGTCACCGC AACGAGACCG GAT
- Page 149 and 150: Consensus MSPQRDRINA FYKDNPYPKG SRI
- Page 151 and 152: Consensus MGLKVNVSAI FMAVLLTLQT PAG
- Page 153 and 154: Aaby, P., Bukh, J., Lisse, I. M. &
- Page 155 and 156: Bouteille, M., Fontaine C., Vedrenn
- Page 157 and 158: Davenport, M. P., Quinn, C. L., Chi
- Page 159 and 160: Foege, W. (1971). Measles vaccinati
- Page 161 and 162: Griffin, D. E., Ward, B. J., Jaureg
- Page 163 and 164: Holt, E. A., Moulton, L. H., Siberr
- Page 165 and 166: Kok, P. W., Kenya, P. R. & Ensering
- Page 167 and 168: Markowitz, L. E., Albrecht, P., Rho
- Page 169 and 170: Norrby, E., Enders-Ruckles, G. & Me
- Page 171 and 172: Poland, G. A., Jacobson, R. M., Col
- Page 173: Siber, G. R., Werner, B. G., Halsey
- Page 177 and 178: WHO, World Health Organisation, Exp
- Page 179 and 180: TABLE DES ILLUSTRATIONS Figure 1. R
- Page 181: Abstract Despite the availability o